"WE ARE CONTINUING TO TACKLE SOME OF THE MOST IMPORTANT CHALLENGES."

- Ken Frazier, Chairman and Chief Executive Officer, Merck

 

This week at IDWeek, the annual infectious diseases scientific meeting, Merck will be presenting important new antibiotics and HIV data, demonstrating our ongoing commitment to addressing unmet medical needs.

"For more than a century, Merck has been passionate about helping to combat this global health issue," says Ken Frazier, Merck chairman and CEO. "From our early work in vaccine discovery, to developing one of the first antibiotics, to delivering medicines to treat HIV, to our work in hepatitis C, we have brought forward vaccines and medicines to help prevent or treat serious and sometimes life-threatening infectious diseases."

OUR WORK IS NOT DONE

Merck is committed to ongoing scientific research and discovery in infectious diseases. We are driven by the conviction that more medical advances are still to come.

Merck's Commitment
to Infectious Disease

For more than 100 years, our company has contributed to the discovery and development of novel medicines and vaccines to treat and prevent infectious diseases.
Learn more

Helping Protect
Future Generations

Mike Nally, president of Merck Vaccines, on Merck's commitment to helping protect current and future generations from vaccine-preventable diseases.
Learn more